John C Hoefs

Title(s)Professor Emeritus, Medicine
Address1001 Health Sciences Road
Irvine CA 92697-3950
Phone(714) 456-7518
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Prevention of the Paracentesis-Induced Circulatory Dysfunction (PICD) in Cirrhosis: Is the SPA Treatment Worthwhile? Dig Dis Sci. 2016 10; 61(10):2773-2775. Hoefs JC. PMID: 27553694.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. A Phase II Randomized, Controlled Trial of S-Adenosylmethionine in Reducing Serum a-Fetoprotein in Patients with Hepatitis C Cirrhosis and Elevated AFP. Cancer Prev Res (Phila). 2015 Sep; 8(9):864-72. Morgan TR, Osann K, Bottiglieri T, Pimstone N, Hoefs JC, Hu KQ, Hassanein T, Boyer TD, Kong L, Chen WP, Richmond E, Gonzalez R, Rodriguez LM, Meyskens FL. PMID: 26130251.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    3. Functional elements associated with hepatic regeneration in living donors after right hepatic lobectomy. Liver Transpl. 2013 Mar; 19(3):292-304. Everson GT, Hoefs JC, Niemann CU, Olthoff KM, Dupuis R, Lauriski S, Herman A, Milne N, Gillespie BW, Goodrich NP, Everhart JE. PMID: 23239552.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    4. Quantitative liver function tests improve the prediction of clinical outcomes in chronic hepatitis C: results from the Hepatitis C Antiviral Long-term Treatment Against Cirrhosis Trial. Hepatology. 2012 Apr; 55(4):1019-29. Everson GT, Shiffman ML, Hoefs JC, Morgan TR, Sterling RK, Wagner DA, Lauriski S, Curto TM, Stoddard A, Wright EC, HALT-C Trial Group . PMID: 22030902.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    5. Very low viral load (VLVL) relapse following treatment of naïve patients with chronic hepatitis C. Dig Dis Sci. 2012 Jan; 57(1):243-9. Hoefs JC, Aulakh VS, Ilagan BJ. PMID: 22139019.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    6. Clinical presentation of hepatocellular carcinoma (HCC) in Asian-Americans versus non-Asian-Americans. J Immigr Minor Health. 2011 Oct; 13(5):842-8. Wong PY, Xia V, Imagawa DK, Hoefs J, Hu KQ. PMID: 20890660.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    7. Frequency of elevated hepatocellular carcinoma (HCC) biomarkers in patients with advanced hepatitis C. Am J Gastroenterol. 2012 Jan; 107(1):64-74. Sterling RK, Wright EC, Morgan TR, Seeff LB, Hoefs JC, Di Bisceglie AM, Dienstag JL, Lok AS. PMID: 21931376.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    8. Rate of progression of hepatic fibrosis in patients with chronic hepatitis C: results from the HALT-C Trial. Gastroenterology. 2011 Sep; 141(3):900-908.e1-2. Hoefs JC, Shiffman ML, Goodman ZD, Kleiner DE, Dienstag JL, Stoddard AM, HALT-C Trial Group . PMID: 21699796.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    9. Testing beneficial therapy in human cirrhosis using animal models of cirrhosis. Dig Dis Sci. 2011 Apr; 56(4):929-30. Hoefs JC, Morgan T, Ilagan BJ. PMID: 21365242.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    10. The clinical presentation of chronic hepatitis B virus infection in Asian Americans: a single center retrospective study. J Clin Gastroenterol. 2010 May-Jun; 44(5):364-70. Mellen JS, Xia VW, Hashemzadeh M, Imagawa D, Jamal M, Hoefs J, Hu KQ. PMID: 19770675.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    11. Prognostic value of Ishak fibrosis stage: findings from the hepatitis C antiviral long-term treatment against cirrhosis trial. Hepatology. 2010 Feb; 51(2):585-94. Everhart JE, Wright EC, Goodman ZD, Dienstag JL, Hoefs JC, Kleiner DE, Ghany MG, Mills AS, Nash SR, Govindarajan S, Rogers TE, Greenson JK, Brunt EM, Bonkovsky HL, Morishima C, Litman HJ, HALT-C Trial Group . PMID: 20101752.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    12. Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C. Hepatology. 2009 Nov; 50(5):1360-9. Freedman ND, Everhart JE, Lindsay KL, Ghany MG, Curto TM, Shiffman ML, Lee WM, Lok AS, Di Bisceglie AM, Bonkovsky HL, Hoefs JC, Dienstag JL, Morishima C, Abnet CC, Sinha R, HALT-C Trial Group . PMID: 19676128.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    13. Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma. Gastroenterology. 2010 Feb; 138(2):493-502. Lok AS, Sterling RK, Everhart JE, Wright EC, Hoefs JC, Di Bisceglie AM, Morgan TR, Kim HY, Lee WM, Bonkovsky HL, Dienstag JL, HALT-C Trial Group . PMID: 19852963.
      View in: PubMed   Mentions: 187     Fields:    Translation:Humans
    14. Effect of HCV RNA suppression during peginterferon alfa-2a maintenance therapy on clinical outcomes in the HALT-C trial. Gastroenterology. 2009 Dec; 137(6):1986-94. Shiffman ML, Morishima C, Dienstag JL, Lindsay KL, Hoefs JC, Lee WM, Wright EC, Naishadham D, Everson GT, Lok AS, Di Bisceglie AM, Bonkovsky HL, Ghany MG, HALT-C Trial Group . PMID: 19747918.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    15. Evolution of hepatic steatosis in patients with advanced hepatitis C: results from the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial. Hepatology. 2009 Jun; 49(6):1828-37. Lok AS, Everhart JE, Chung RT, Kim HY, Everson GT, Hoefs JC, Greenson JK, Sterling RK, Lindsay KL, Lee WM, Di Bisceglie AM, Bonkovsky HL, Ghany MG, Morishima C, HALT-C Trial Group . PMID: 19291787.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    16. Seventy-two weeks of peginterferon and ribavirin for patients with partial early virologic response? Hepatology. 2007 Dec; 46(6):1671-4. Hoefs JC, Morgan TR. PMID: 18046713.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    17. Impact of disease severity on outcome of antiviral therapy for chronic hepatitis C: Lessons from the HALT-C trial. Hepatology. 2006 Dec; 44(6):1675-84. Everson GT, Hoefs JC, Seeff LB, Bonkovsky HL, Naishadham D, Shiffman ML, Kahn JA, Lok AS, Di Bisceglie AM, Lee WM, Dienstag JL, Ghany MG, Morishima C, HALT-C Trial Group . PMID: 17133499.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    18. Roles of iron and HFE mutations on severity and response to therapy during retreatment of advanced chronic hepatitis C. Gastroenterology. 2006 Nov; 131(5):1440-51. Bonkovsky HL, Naishadham D, Lambrecht RW, Chung RT, Hoefs JC, Nash SR, Rogers TE, Banner BF, Sterling RK, Donovan JA, Fontana RJ, Di Bisceglie AM, Ghany MG, Morishima C, HALT-C Trial Group . PMID: 17101320.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCTClinical Trials
    19. Noninvasive evaluation of liver disease severity. Clin Liver Dis. 2006 Aug; 10(3):535-62, viii-ix. Hoefs JC, Chen PT, Lizotte P. PMID: 17162227.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    20. Treatment of chronic HCV infection in special populations. Int J Med Sci. 2006; 3(2):69-74. Hoefs J, Aulakh VS. PMID: 16614746.
      View in: PubMed   Mentions: 5     Fields:    
    21. Factors affecting the quantitative liver-spleen scan in normal individuals. Dig Dis Sci. 2005 Feb; 50(2):283-9. Hoefs JC, Sheikh MY, Guerrero H, Milne N. PMID: 15745086.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    22. Precore mutant hepatitis B reactivation after treatment with CHOP-rituximab. Anticancer Drugs. 2005 Jan; 16(1):83-5. Zell JA, Yoon EJ, Ignatius Ou SH, Hoefs JC, Chang JC. PMID: 15613909.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    John's Networks
    Concepts (136)
    Derived automatically from this person's publications.
    _
    Co-Authors (4)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _